Green Cross Health Ltd · NZX:GXH
Green Cross Health — Shareholder Meeting (August 2020)
33 slides from Green Cross Health's shareholder meeting presentation, Aug 24, 2020
Slide 1: Annual Shareholders' Meeting
Annual Shareholders’ Meeting 24 August 2020 GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 1
Slide 2: Attendees - Question Process
Attendees- Question Process 1. When the Question function is available, the Q&A icon will appear at the top of the app 2. To send in a question, simply click in the ‘Ask a question’ box, type your question and then press the send arrow 3. Your question will be sent immediately for review GXH Annual
Slide 3: Kim Ellis, Chair
Kim Ellis Chair GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 3
Slide 4: Board of Directors
Board of Directors Speakers: Kim Ellis Rachael Newfield Ben Doshi Chair Group CEO Group CFO/ Company Secretary Other Board members: Andrew Bagnall John Bolland Peter Merton Ken Orr Carolyn Steele Peter Williams Non-Executive Director Non-Executive Director Non-Executive Director Independent Director
Slide 5: Agenda
Agenda • Chair’s address • Group CEO’s address • Q&A • Voting on Resolutions • General Q&A GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 5
Slide 6: Business Update: COVID-19, Balance sheet, Dividend
Business Update • COVID-19 • Balance sheet • Dividend GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 6
Slide 7: Rachael Newfield, Group CEO
Rachael Newfield Group CEO GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 7
Slide 8: Our Purpose
Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 8
Slide 9: Financial Highlights
Financial Highlights Revenue Pharmacy $568.5m 0.2% Same store sales 1.5% Operating Profit/EBIT Medical Operating Profit $31.0m¹ 5.4% $8.0m3 81.1% Net Profit After Tax Community Health (attributable to shareholders) Operating Profit $13.5m² -16.2% $2.5m +$2.4m Note: 1 Net operating profit before IFRS
Slide 10: Group Revenue and Profit
Group Revenue and Profit GXH Operating Revenue GXH Operating Profit $m $m 600 40 34.9 567.2 568.5 35 30.0 31.0 29.4 550 537.2 30 25 500 487.6 20 15 450 10 5 400 0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 Adjustment • Revenue marginally increased to $568.5m • Operating Profit of $31.0m, up 5.4
Slide 11: Net Profit After Tax (attributable to shareholders)
Net Profit After Tax (attributable to shareholders) GXH Net Profit after Tax Attributable to Shareholders $m 20.0 17.0 15.6 16.1 14.1 15.0 13.5 10.0 5.0 0.0 2017 2018 2019 2020 IFRS 16 Adjustment • NPAT attributable to shareholders of $13.5m, down 16.2% • NPAT attributable to shareholders of $17.6m
Slide 12: Operating Cash / Investments
Operating Cash / Investments GXH Operating Cash Flow $m 60 54.3 • Operating Cash of $54.3m ($34.8m before the 55 application of IFRS 16) 50 45 40 Enabling investment ($10.8m) in: 35 33.1 31.4 • Drury Surgery (new holding) 29.9 30 • Karori pharmacies (two new holdings) 25 • Waiuku Medical Pharmacy (i
Slide 13: Net Debt / Debt Capacity
Net Debt / Debt Capacity Net Debt (Borrowings Less Cash) $m 0 2017 2018 2019 2020 • $10m improvement in Net Debt to $22.6m -5 • Debt facilities with BNZ mature 22 August 2022 -10 • $10m of headroom on BNZ group debt facility -15 • Strong Balance Sheet will help absorb COVID-19 -20 and economic downt
Slide 14: Earnings Per Share
Earnings Per Share Earnings Per Share Cps 16 14.18 14 • EPS at 9.42 cps (9.85 cps before the 12 application of IFRS 16) 11.02 11.25 9.85 10 9.42 8 6 4 2 0 2017 2018 2019 2020 IFRS 16 adjustment GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 14
Slide 15: Divisional Plans
Divisional Plans GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 15
Slide 16: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue Pharmacy Operating Profit $m $m 350 32 28.9 27.9 27.3 341.3 340.2 28 340 336.4 22.5 24 330 20 322.6 16 320 12 8 310 4 300 0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 Adjustment • Revenue down 1% at $336.4m, following some store closures as part o
Slide 17: Pharmacy Future Focus
Pharmacy Future Focus Retail Disciplines • Evolve retail offering to changing consumer behaviour post COVID-19 • Focus on margin management Customer Engagement • Strengthen digital capability around 1.7m Living Rewards database • Grow e-commerce • Advocate for removal of $5 prescription co-payment t
Slide 18: Medical Performance
Medical Performance Medical Operating Revenue Medical Operating Profit $m $m 90 9 8.0 80 76.5 8 70.5 70 7 60 52.7 6 49.3 50 5 4.4 40 4 3.7 2.9 30 3 20 2 10 1 0 0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 adjustment • Revenue up 8.5% to $76.5m, primarily as a result of organic growth • Operatin
Slide 19: Medical Future Focus
Medical Future Focus Network Scale • Continue to build The Doctors brand • Network and patient number growth through targeted acquisitions and organic revenue growth Patient Engagement • Deploy digital technology to increase efficiency and enhance delivery of high quality patient care • Work closely
Slide 20: Community Health Performance
Community Health Performance Community Health Operating Revenue Community Health Operating Profit $m $m 180 3.5 156.5 155.6 3.0 160 143.2 3.0 140 2.5 115.7 2.5 120 100 2.0 80 1.5 1.2 60 1.0 40 20 0.5 0.1 0 0.0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 adjustment • Revenue down 0.5% to $155.6m
Slide 21: Community Health Future Focus
Community Health Future Focus Service Offering • Focus on higher clinical needs segments • Expand geographic coverage of Community Nursing business Digital Communication • Harness technology to enhance workforce efficiency and client outcomes Financial Returns • Continue cost reduction initiatives •
Slide 22: Q&A
Q&A GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 22
Slide 23: Resolutions & Voting
Resolutions & Voting GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 23
Slide 24: Attendees - Voting Process
Attendees – Voting Process 1. When the poll is open, the vote will be accessible by selecting the voting icon at the top of the screen 2. To vote simply select the option you wish to send, the selected option will change colour GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 202
Slide 25: Resolutions
Resolutions • Resolution 1: Election of Kim Ellis • Resolution 2: Re-election of Peter Williams • Resolution 3: Re-election of Andrew Bagnall • Resolution 4: Re-election of John Bolland • Resolution 5: Re-election of Carolyn Steele • Resolution 6: Remuneration of the Auditor GXH Annual Shareholders’
Slide 26: Resolution 1 - Election of Kim Ellis
Resolution 1 – Election of Kim Ellis Kim Ellis to be elected as Director of the Company GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 26
Slide 27: Resolution 2 - Re-election of Peter Williams
Resolution 2 – Re-election of Peter Williams Peter Williams to be re-elected as Director of the Company GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 27
Slide 28: Resolution 3 - Re-election of Andrew Bagnall
Resolution 3 – Re-election of Andrew Bagnall Andrew Bagnall to be re-elected as Director of the Company GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 28
Slide 29: Resolution 4 - Re-election of John Bolland
Resolution 4 – Re-election of John Bolland John Bolland to be re-elected as Director of the Company GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 29
Slide 30: Resolution 5 - Re-election of Carolyn Steele
Resolution 5 – Re-election of Carolyn Steele Carolyn Steele to be re-elected as Director of the Company GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 30
Slide 31: Resolution 6 - Remuneration of the Auditor
Resolution 6 – Remuneration of the Auditor To authorise the Directors to fix the remuneration of the Auditor for the ensuing year GXH Annual Shareholders’ Meeting Presentation 24 24August August2020 2020 Pg 31
Slide 32: Q&A
Q&A GXH Annual Shareholders’ Meeting Presentation 24 August 2020 Pg 32
Slide 33: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability
Green Cross Health — Shareholder Meeting (August 2020) on 6ix